News - Lexicon Pharmaceuticals, Research

Filter

Popular Filters

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102

17-12-2012

US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Back to top